With the analysis among 99 patents, we discovered top 35 key players by total patent application. Otsuka Pharmaceutical Co., Ltd., KOREA UNITED PHARM, Inc., KOREAN DRUG Co., Ltd. are dominant in this area. They take 43.43% of the total patent filing.
Tokyo-to, Japan
Patent: 31
Gyeonggi-do, South Korea
Patent: 5
California, United States
Patent: 4
Taiwan Province, China
Patent: 3
Shandong Sheng, China
Patent: 3
No data, please try another search term
With the analysis among related 38 patents applied in the last 5 years. We discover 26 most active companies in this area. The fast-growing Neurondawn Pharmaceutical Co., Ltd., KOREAN DRUG Co., Ltd., KOREA UNITED PHARM, Inc. take 31.58% of patent filing during this period.
Gyeonggi-do, South Korea
Patent: 4
Shandong Sheng, China
Patent: 3
Shandong Sheng, China
Patent: 2
Kagoshima-ken, Japan
Patent: 2
Shanghai Shi, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Hunan Sheng, China
Patent: 1
With the analysis among related 38 patents in last 5 years, we discover 22 new entrants. Neurondawn Pharmaceutical Co., Ltd., Yantai Yisheng Pharmaceutical Co. Ltd., National Cerebral & Cardiovascular Center are the most active new entrants in this area.
Shandong Sheng, China
Patent: 3
Kagoshima-ken, Japan
Patent: 2
Zhejiang Sheng, China
Patent: 1
Shanghai Shi, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Hunan Sheng, China
Patent: 1
With the analysis among 6 patents, we discovered top 7 universities and scientific research institutions by total patent application. King's College London, University of Vermont, Warszawski Uniwersytet Medyczny are dominant in this area. They take 50.00% of the total patent filing.
Massachusetts, United States
Patent: 1
Mazowieckie, Poland
Patent: 1
Shizuoka-ken, Japan
Patent: 1